Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker.

Zahran, Asmaa M; Nafady-Hego, Hanaa; Moeen, Sawsan M; Eltyb, Hanan A; Wahman, Mohammed M; Nafady, Asmaa

Zahran, Asmaa M; Nafady-Hego, Hanaa; Moeen, Sawsan M; Eltyb, Hanan A; Wahman, Mohammed M; Nafady, Asmaa.

Afiliación

Zahran AM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Nafady-Hego H; Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Moeen SM; Department of Internal Medicine, Clinical Haematology Unit, Faculty of Medicine, Assiut University, Assiut, Egypt.
Eltyb HA; Department of Medical Oncology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Wahman MM; Department of Clinical Oncology, South Valley University, Qena, Egypt.
Nafady A; Department of Clinical and Chemical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt.

Afr J Lab Med ; 11(1): 1713, 2022.

Article en En | MEDLINE | ID: mdl-35402200

RESUMEN

[This corrects the article DOI: 10.4102/ajlm.v10i1.1296.].

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Afr J Lab Med Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Sudáfrica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google